News

AI Meets Genome Sequencing and the Health Data Explosion to Transform Medicine

AI Meets Genome Sequencing and the Health Data Explosion to Transform Medicine

We’ve discussed the questions of “nature vs nurture”, personalized medicine and the privacy of genomics data with Dr. Wim Van Criekinge, Chief Life Science Officer at doc.ai.
Read more
Wobblebase genome importer from Novalis integrated in doc.ai medical data platform

Wobblebase genome importer from Novalis integrated in doc.ai medical data platform

In October 2018, Wobblebase’s genome importer has been integrated in the doc.ai platform. Biotech incubator Novalis is now the second largest external shareholder in doc.ai.
Read more
MyNeo has been officially launched today!

MyNeo has been officially launched today!

Ghent, 27th December 2018. MyNeo has started its life as an independent entity! MyNeo is a Belgian biotech company, based in Ghent, focused on identifying, exploring and validating personalized cancer treatments.
Read more
Launch of BioLizard’s website, lizard.bio!

Launch of BioLizard’s website, lizard.bio!

Today we announce the launch of lizard.bio, where we describe our experience in bioinformatics, biostatistics and machine learning, applied to the biotechnology field.
Read more
De Tijd interviews Novalis’s founders

De Tijd interviews Novalis’s founders

De Tijd journalist Jan De Schamphelaere discusses the launch of Novalis with our founders, from their previous careers to the current state of the fund.
Read more
Novalis founds first three companies

Novalis founds first three companies

We are proud to announce to the world the incorporation of BioLizard, OHMX.bio and MyNeo.
Read more
Novalis becomes a member of flanders.bio

Novalis becomes a member of flanders.bio

Novalis makes its entry in the Flemish biotech scene, and invites resumés to fill various positions. We’re also interested in learning about your latest research, if you are a professor or PhD student.
Read more
Tijd article gives extra weight to Novalis’ mission

Tijd article gives extra weight to Novalis’ mission

Met een stroom positief nieuws kregen we de voorbije week weer een biotechbonanza. Jo Bury en Rudy Dekeyser, de founding fathers van het Vlaams Instituut voor Biotechnologie, maken de balans op. ‘In Europa is Vlaanderen het nummer 1. Met voorsprong.’
Read more